Urinary Tract Infection
📧 Sign up to get email alerts when something new happens for Urinary Tract Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-06-15FDA Approved: TRIMETHOPRIM — Original Application (Novel Laboratories, Inc.)
FDA approved Novel Laboratories, Inc.'s original application for trimethoprim, establishing a generic supplier of the antibiotic.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated Urinary Tract Infection and Acute Pyelonephritis. [Phase 3]
Phase 3 trial comparing levofloxacin to ciprofloxacin for complicated urinary tract infection and acute pyelonephritis has completed. The st…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis [Phase 3]
A completed Phase 3 trial evaluating doripenem for complicated urinary tract infections and pyelonephritis.
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections [Phase 3]
Phase 3 trial comparing oral levofloxacin to oral ciprofloxacin for complicated urinary tract infections has completed, assessing safety and…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Procalcitonin Level and Kinetics in Children With Bacterial Infections
A completed pediatric trial evaluating procalcitonin levels and their kinetics in children with various bacterial infections to explore pote…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-05-11FDA Approved: NITROFURANTOIN — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved the original application for nitrofurantoin from Amneal Pharmaceuticals NY LLC, granting marketing approval for this generic pr…
-
CLINICAL_TRIALS trial_result · 2011-04-28Clinical Trial Update: Cefpodoxime vs Ciprofloxacin for Acute Cystitis [NA]
A completed clinical trial comparing cefpodoxime to ciprofloxacin for acute cystitis has posted results.
-
CLINICAL_TRIALS research · 2011-03-07Clinical Trial Update: Day Zero Urinary Catheter Removal in Gen Thoracic Surgery Patients
This clinical trial update examines removing urinary catheters on day zero after general thoracic surgery. It is sponsored by Memorial Healt…
-
FDA approval · 2011-02-22FDA Approved: CEPHALEXIN — Supplemental Application (AVKARE)
The FDA approved a supplemental application for Cephalexin from AvKare.
-
FDA approval · 2011-01-27FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for amoxicillin and clavulanate potassium (Hikma Pharmaceuticals USA Inc.), updating the product…
-
FDA approval · 2010-12-20FDA Approved: CEPHALEXIN — Original Application (AvPAK)
FDA approved the original application for Cephalexin (generic) from AvPAK under ANDA090836.
-
FDA approval · 2010-11-29FDA Approved: CEFAZOLIN — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for Cefazolin (cefazolin sodium) from Fresenius Kabi USA, LLC, updating an already approved prod…
-
CLINICAL_TRIALS trial_result · 2010-11-01Clinical Trial Update: Efficacy of Two Prophylactic Schedules (Prulifloxacin Versus Phosphomycin) [Phase 2]
This document reports a Phase 2 clinical trial comparing two prophylactic antibiotic regimens—prulifloxacin and phosphomycin—for preventing …
-
FDA approval · 2010-10-27FDA Approved: NITROFURANTOIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Nitrofurantoin submitted by Rising Pharma Holdings, Inc.
-
FDA approval · 2010-10-14FDA Approved: NITROFURANTOIN — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Nitrofurantoin submitted by Rising Pharma Holdings, Inc. The approval involves a supplement …
-
CLINICAL_TRIALS trial_result · 2010-09-23Clinical Trial Update: Cranberry for UTI Prevention in Residents of Long Term Care Facilities [NA]
A clinical trial evaluating cranberry products to prevent urinary tract infections in residents of long-term care facilities has completed a…
-
CLINICAL_TRIALS trial_result · 2010-07-09Clinical Trial Update: Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054) [Phase 3]
A Phase 3 trial evaluating MK0826 with other antibiotic therapy for complicated urinary tract infections was terminated, and results have be…
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: Vitamin C for Prevention of Urinary Tract Infections in the Spinal Cord Injured [Phase 4]
A Phase 4 trial investigating whether vitamin C can prevent urinary tract infections in people with spinal cord injuries has been terminated…
-
CLINICAL_TRIALS trial_result · 2010-06-29Clinical Trial Update: Efficacy and Safety of Cefditoren Pivoxil Versus Ciprofloxacin in Acute Uncomplicated Cystitis [Phase 3]
A Phase 3 trial comparing cefditoren pivoxil to ciprofloxacin in acute uncomplicated cystitis reports efficacy and safety data.
-
CLINICAL_TRIALS research · 2010-06-07Clinical Trial Update: Clinical Significance and Optimal Treatment of Community-onset Urinary Tract Infections Caused by Extended-spectrum β-lactamase and/or AmpC β-lactamase Producing Enterobacteriaceae
Clinical trial update examining the clinical significance and optimal treatment of community-onset urinary tract infections caused by ESBL/A…
-
CLINICAL_TRIALS trial_result · 2010-05-07Clinical Trial Update: UTI Prophylaxis Using Bacterial Interference Following SCI [Phase 2]
Phase 2 trial evaluating prophylaxis of urinary tract infections after spinal cord injury using bacterial interference has completed.
-
FDA label_change · 2010-04-27FDA Approved: CEFACLOR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Cefaclor by Teva, updating the product labeling.
-
CLINICAL_TRIALS trial_result · 2010-03-24Clinical Trial Update: Efficacy and Safety of Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infections in Adults [Phase 4]
Phase 4 clinical trial updating on the efficacy and safety of nitrofurantoin for uncomplicated urinary tract infections in adults; the study…
-
CLINICAL_TRIALS research · 2010-03-08Clinical Trial Update: Treatment and/or Prevention of Urinary Tract Infections [Phase 1]
A Phase 1 clinical trial update by Biomedical Development Corporation on treatment and/or prevention of urinary tract infections, including …
-
CLINICAL_TRIALS trial_result · 2010-03-01Clinical Trial Update: Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055) [Phase 3]
Phase 3 clinical trial assessing the safety and tolerability of ertapenem sodium for the treatment of complicated urinary tract infections; …